Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 171 - 180 of 317

Selected Filters:
2 November 2022

PrEP-Related Stigma and PrEP Use among Gay, Bisexual and Other Men who Have Sex with Men in Ontario and British Columbia, Canada

This article from AIDS Research and Therapy explores the association between PrEP-related stigma and PrEP use amongst gay and bisexual men who have sex with men in Ontario and British Columbia, Canada.

Research, Service Delivery

External Link
1 November 2022

The Importance of Assessing and Addressing Mental Health Barriers to PrEP Use during Pregnancy and Postpartum in Sub-Saharan Africa: State of the science and research priorities

This article from the Journal of the International AIDS Society highlights key research priorities that can support PrEP adherence and persistence during pregnancy and the post-partum period by addressing mental health barriers.

Research, Service Delivery

External Link
20 October 2022

Dual Prevention Pill Research Insights & Development of Strategic Themes

This presentation, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.

Research

Presentation
20 October 2022

Results of 90 Day Tenofovir plus Levonorgestrel Vaginal Ring Trial: The CONRAD 138 study

This article from PLOS One presents the results of a randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics, and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women to prevent both pregnancy and HIV.

Research

External Link
14 October 2022

Long-acting injectable cabotegravir for HIV prevention: WHO guidelines, implementation considerations, and project examples

Recording During this 90-minute webinar, speakers will provide an overview of the new WHO guidelines on CAB for PrEP, discuss implementation issues specifically relating to HIV testing and drug resistance, and highlight examples of planned implementation projects in sub-Saharan Africa and Asia. This webinar is presented by the Global PrEP Network, a WHO-led forum designed…

Research, Normative Guidance/Policies, Testing

Event
13 October 2022

Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study

This article from the Journal of the International AIDS Society assesses factors associated with long-term PrEP engagement and adherence among trans women enrolled in the Implementation of PrEP (ImPrEP) study, the largest PrEP demonstration study in Latin America.

Research

External Link
6 October 2022

Socio-behavioral Correlates of Pre-exposure Prophylaxis Use and Correct Adherence in Men who have Sex with Men in West Africa

This article from BMC Public Health reports on results from the CohMSM study in Burkina Faso, Côte d’Ivoire, Mali, and Togo relating to PrEP adherence amongst gay and bisexual men who have sex with men.

Research

External Link
4 October 2022

Acceptability of Injectable Pre-exposure Prophylaxis among People who Inject Drugs in Three Urban U.S. Settings

This article from BMC Infectious Diseases examines acceptability of injectable PrEP amongst people who inject drugs in the US.

Research

External Link
4 October 2022

Long-Acting Injectable Cabotegravir for HIV Prevention: What do we know and need to know about the risks and consequences of cabotegravir resistance?

This article from The Science of Prevention summarizes what is known about cabotegravir (CAB) pharmacokinetics, activity, and emergence of resistance from in vitro, macaque and clinical studies, and evaluates the risk of resistance from CAB for PrEP with on-time injections and after CAB for PrEP discontinuation.

Monitoring & Evaluation, Research, Testing

External Link
16 September 2022

Engaging HIV-Prevention Ambassadors to Promote Oral PrEP among Adolescent Girls and Young Women: Results of a Zimbabwe field test

This article from the African Journal of AIDS Research describes the results of a field test of the HIV Prevention Ambassador Training Package for Adolescent Girls and Young Women, a toolkit designed to improve skills, knowledge, and attitudes about oral PrEP among peer ambassadors.

Community/Advocacy, Demand Creation/Marketing, Research

External Link